A Phase 2 interventional study of Paracetamol hot drink and Paracetamol tablets in Common Cold, sponsored by GlaxoSmithKline. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-02-18.
Sponsored by GlaxoSmithKline · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Common Cold with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Common Cold · United Kingdom.
Among the 20 studies in Common Cold with a site in United Kingdom, this one is the 6th largest by enrollment, is the only one that started in 2010, is one of 4 in phase 2, and was the 4th registered.
219 studies on the registry are indexed under Common Cold; 23 are open to participants now.
Browse Common Cold studies →None of the 20 studies in Common Cold with a site in United Kingdom is open now. The open studies under Common Cold, anywhere →
Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is above the median of 150 across 184 interventional studies indexed under Common Cold.
Median enrollment 89 across the 20 interventional studies. Of the 17 that completed or were terminated, 7 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 20 have an industry lead sponsor. The 10 most frequent:
GlaxoSmithKline is the lead sponsor of 3,652 studies on the registry; 118 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 241 (90%) have results posted.
GlaxoSmithKline has 9 studies filed under Common Cold — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Common Cold with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to subjectively assess symptoms in subjects suffering from the common cold following a single dose of paracetamol hot drink compared to paracetamol tablet
Inclusion Criteria:
Hot drink containing paracetamol
Drug: Paracetamol hot drink
Paracetamol tablets
Drug: Paracetamol tablets
Hot drink containing paracetamol
Paracetamol tablets
Breathing Scores Post 15 Minutes
A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
Time frame: Baseline to 15 minutes
Breathing Score Post 60 Minutes
A mean breathing score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
Time frame: Baseline to 60 minutes
Cold Symptoms Score Post 15 Minutes
A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
Time frame: Baseline to 15 minutes
Cold Symptoms Score Post 60 Minutes
A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
Time frame: Baseline to 60 minutes
Soothing Attribute Scores
Soothing attribute of test treatment was assessed by asking the question "if the hot drink is soothing" at baseline, 15 and 60 minutes. The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.
Time frame: Baseline to 15 and 60 minutes
Overall Cold Symptoms Score
Overall cold symptom score was assessed by asking the question "my cold symptoms are improved" only post consuming the drink at baseline, 15 and 60 minutes . The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.
Time frame: Baseline to 15 and 60 minutes
Participants were recruited at the clinical site.
| Milestone | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Started | 100 | 100 |
| Completed | 100 | 100 |
| Not completed | 0 | 0 |
A mean breathing score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
| Score on a Scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Breathing Scores Post 15 Minutes | 0.83 (0.73 to 0.93) | 0.11 (0.01 to 0.21) |
A mean breathing score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes, derived from participant responses to questions relating to breathing i.e. "my breathing feels easy", "I feel airways are open", "I feel a cooling sensation in my throat", "I can feel the air flowing to my lungs easily", "My nose feels less blocked" and "I feel my breathing is comfortable". The breathing scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
| Score on a scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Breathing Score Post 60 Minutes | 0.92 (0.81 to 1.02) | 0.34 (0.23 to 0.44) |
A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5 and 15 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
| Score on a scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Cold Symptoms Score Post 15 Minutes | 0.64 (0.52 to 0.75) | 0.13 (0.02 to 0.25) |
A mean Cold symptom score was calculated at baseline, 30 seconds, 2, 5, 15 and 60 minutes from participant responses to questions relating to cold symptoms i.e. "My head feels clear", "I feel soothing in my throat" and "I feel my cough is being soothed". The cold symptom scores were rated by the participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'. For each participant, a mean score was derived by summing the responses and dividing by the number of questions answered.
| Score on a scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Cold Symptoms Score Post 60 Minutes | 0.87 (0.76 to 0.99) | 0.35 (0.24 to 0.46) |
Soothing attribute of test treatment was assessed by asking the question "if the hot drink is soothing" at baseline, 15 and 60 minutes. The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.
| Score on a scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Average effect over first 15 minutes | 2.3 ± 0.80 | 1.2 ± 0.88 |
| Average effect over 60 minutes | 2.4 ± 0.72 | 1.3 ± 0.88 |
Overall cold symptom score was assessed by asking the question "my cold symptoms are improved" only post consuming the drink at baseline, 15 and 60 minutes . The response to the question was rated by participants on a 5 point (0-4) rating scale with '0' being labeled as 'strongly disagree' and '4' being labeled as 'strongly agree'.
| Score on a scale | Mentholated Paracetamol Hot Drink | Paracetamol Tablet |
|---|---|---|
| Average effect over first 15 minutes | 1.8 ± 0.86 | 0.9 ± 0.63 |
| Average effect over 60 minutes | 2.1 ± 0.75 | 1.3 ± 0.62 |
Collected over Adverse events were collected from the start of the treatment, and until 5 days following administration of the last dose of investigational product.. Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Mentholated Paracetamol Hot Drink | — | 0/100 (0%) | 0/100 (0%) |
| Paracetamol Tablets | — | 0/100 (0%) | 0/100 (0%) |
| Age, Continuous(Years) | Mentholated Paracetamol Hot Drink | Paracetamol Tablet | Total |
|---|---|---|---|
| Mean | 20.0 ± 1.85 | 20.0 ± 1.98 | 20.0 ± 1.92 |
| Sex: Female, Male(Participants) | Mentholated Paracetamol Hot Drink | Paracetamol Tablet | Total |
|---|---|---|---|
| Female | 65 | 63 | 128 |
| Male | 35 | 37 | 72 |
The record gives a start of Oct 2010, a primary completion of Dec 2010 and a completion of Dec 2010. It does not say whether these dates are actual or estimated.
Results were first posted in Feb 2015, 4 years 2 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Acetaminophen